Isomorphic Labs receives $2.1bn for AI drug development.

{
  "signal_id": "18bc31db-6703-4dbf-aa1b-f7f0bce4512d",
  "signal_type": "news",
  "signal_subtype": "is_developing",
  "detected_at": "2026-05-13T08:07:33+00:00",
  "company": {
    "name": "Isomorphic Labs",
    "domain": "isomorphiclabs.com"
  },
  "data": {
    "url": "https://www.hospitalmanagement.net/news/isomorphic-labs-ai-drug-development",
    "title": "Isomorphic Labs receives $2.1bn for AI drug development.",
    "excerpt": "Isomorphic Labs receives $2.1bn for AI drug development.\n\nThe proceeds will be used to accelerate Isomorphic Labs' pipeline of therapeutic programmes and further develop its IsoDDE AI drug design engine.\n\nAI drug design and development company Isomorphic Labs has secured $2.1bn in Series B funding to expedite its transition from developing innovative AI models to deploying them on a larger scale.\n\nThe round was led by Thrive Capital, with participation from existing investors Alphabet and GV, as well as new investors CapitalG, MGX, Temasek, and the UK Sovereign AI Fund. This significantly broadens Isomorphic Labs' global capital support.\n\nThe proceeds will also be used to further develop and deploy Isomorphic Labs' AI drug design engine, IsoDDE, and accelerate its pipeline of therapeutic programmes toward clinical stages.\n\nAdditionally, the funding will be used to support hiring by integrating AI, clinical talent, drug design, and engineering and across all sites. The aim is to expand both geographic and scientific reach to address complex biological and medical challenges globally.\n\nIsomorphic Labs president Max Jaderberg said: \"This milestone is built on the strength of its AI drug design engine, which has already proven its worth across its internal programmes by hitting key milestones and identifying viable candidates with unprecedented speed.\n\n\"Our drug design engine...",
    "product": "IsoDDE AI drug design engine",
    "summary": "Isomorphic Labs Limited is developing IsoDDE AI drug design engine.",
    "planning": false,
    "image_url": "https://www.hospitalmanagement.net/wp-content/uploads/sites/9/2026/05/PT-13-05-2026-shutterstock_1884612922.jpg",
    "confidence": 0.7384,
    "product_data": {
      "full_text": "IsoDDE AI drug design engine",
      "fuzzy_match": true
    },
    "product_tags": [
      "medical",
      "future_tech"
    ],
    "published_at": "2026-05-13T08:07:33Z",
    "job_title_tags": [
      "design"
    ],
    "article_sentence": "The proceeds will be used to accelerate Isomorphic Labs' pipeline of therapeutic programmes and further develop its IsoDDE AI drug design engine."
  }
}

curl https://signals.autobound.ai/v1/signals/18bc31db-6703-4dbf-aa1b-f7f0bce4512d \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"isomorphiclabs.com","limit":20}'